文献速递颈动脉与弓上血管

就诊时卒中严重程度与溶栓对紧急颈动脉干预后结局的影响

Impact of presenting stroke severity and thrombolysis on outcomes following urgent carotid interventions.
PubMed 文献 · J Vasc Surg · 2023-06-16

本研究在三级综合卒中中心回顾7年内238例接受紧急颈动脉内膜剥脱术或支架植入术的患者,分为单纯手术组(n=186)与术前溶栓组(n=52)。结果显示就诊时NIHSS越高,出院mRS越差;轻中度卒中患者无论是否溶栓,出院功能独立(mRS≤2)的可能性不受溶栓影响。

要点

  • 溶栓组就诊时卒中严重程度更高(NIHSS 7.6 vs 3.8,P=.001)。
  • 30天死亡率溶栓组更高(9.6% vs 0%,P<.001)。
  • 是否溶栓对出院mRS无显著差异(2.1 vs 1.7,P=.061)。

核心结论

  • 就诊时卒中严重程度(NIHSS)越高,神经功能结局(mRS)越差。
  • 轻度和中度卒中患者无论是否接受tPA,出院时神经功能独立(mRS≤2)的可能性相似。
  • 就诊时NIHSS可预测出院神经功能自主性,且不受溶栓使用影响。

研究设计与样本

  • 回顾性队列研究,纳入2015年1月至2022年5月在三级综合卒中中心接受紧急颈动脉内膜剥脱术或支架植入术的患者238例。
  • 分为单纯手术组(uCEA/uCAS only,n=186)和术前溶栓组(tPA + uCEA/uCAS,n=52)。
  • 结局指标为出院时mRS和30天并发症,采用回归模型分析tPA使用、就诊卒中严重程度与出院神经功能结局的关联。

主要发现

  • 溶栓组较单纯手术组平均就诊卒中严重程度更高(NIHSS 7.6 vs 3.8,P=.001),中重度卒中(NIHSS>4)比例更高(57.7% vs 30.2%)。
  • 30天卒中率单纯手术组 vs 溶栓组为8.1% vs 11.5%(P=.416),30天死亡率0% vs 9.6%(P<.001),30天心肌梗死率0.5% vs 1.9%(P=.39)。
  • 30天卒中/出血转化和心肌梗死率两组的差异无统计学意义,但溶栓组死亡差异显著更高(P<.001)。
  • 出院神经功能结局(平均mRS)溶栓组 vs 单纯手术组为2.1 vs 1.7(P=.061),无显著差异。
  • 轻度卒中(NIHSS≤4 vs >4:相对风险1.58 vs 1.58,tPA vs 无tPA,P=.997)和中度卒中(NIHSS≤10 vs >10:相对风险1.94 vs 2.08,tPA vs 无tPA,P=.891)出院功能独立(mRS≤2)的可能性不受tPA影响。

临床怎么用

  • 作者认为就诊时NIHSS可预测出院神经功能自主性,且不受溶栓使用影响。
  • 作者指出轻度和中度卒中患者无论是否接受tPA,出院时神经功能独立(mRS≤2)的可能性相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carotid interventions are increasingly performed in select patients following acute stroke. We aimed to determine the effects of presenting stroke severity (National Institutes of Health Stroke Scale [NIHSS]) and use of systemic thrombolysis (tissue plasminogen activator [tPA]) on discharge neurological outcomes (modified Rankin scale [mRS]) after urgent carotid endarterectomy (uCEA) and urgent carotid artery stenting (uCAS). METHODS: Patients undergoing uCEA/uCAS at a tertiary Comprehensive Stroke Center (January 2015 to May 2022) were divided into two cohorts: (1) no thrombolysis (uCEA/uCAS only) and (2) use of thrombolysis before the carotid intervention (tPA + uCEA/uCAS). Outcomes were discharge mRS and 30-day complications. Regression models were used to determine an association between tPA use and presenting stroke severity (NIHSS) and discharge neurological outcomes (mRS). RESULTS: Two hundred thirty-eight patients underwent uCEA/uCAS (uCEA/uCAS only, n = 186; tPA + uCEA/uCAS, n = 52) over 7 years. In the thrombolysis cohort compared with the uCEA/uCAS only cohort, the mean presenting stroke severity was higher (NIHSS = 7.6 vs 3.8; P = .001), and more patients presented with moderate to severe strokes (57.7% vs 30.2% with NIHSS >4). The 30-day stroke, death, and myocardial infarction rates in the uCEA/uCAS only vs tPA + uCEA/uCAS were 8.1% vs 11.5% (P = .416), 0% vs 9.6% (P < .001), and 0.5% vs 1.9% (P = .39), respectively. The 30-day stroke/hemorrhagic conversion and myocardial infarction rates did not differ with tPA use; however, the difference in deaths was significantly higher in the tPA + uCEA/uCAS cohort (P < .001). There was no difference in neurological functional outcome with or without thrombolysis use (mean mRS, 2.1 vs 1.7; P = .061). For both minor strokes (NIHSS ≤4 vs NIHSS >4: relative risk, 1.58 vs 1.58, tPA vs no tPA, respectively, P = .997) and moderate strokes (NIHSS ≤10 vs NIHSS >10: relative risk, 1.94 vs 2.08, tPA vs no tPA, respectively; P = .891), the likelihood of discharge functional independence (mRS score of ≤2) was not influenced by tPA. CONCLUSIONS: Patients with a higher presenting stroke severity (NIHSS) had worse neurological functional outcomes (mRS). Patients presenting with minor and moderate strokes were more likely to have discharge neurological functional independence (mRS of ≤2), regardless of whether they received tPA or not. Overall, presenting NIHSS is predictive of discharge neurological functional autonomy and is not influenced by the use of thrombolysis.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hayson A, Burton J, Allen J, et al. Impact of presenting stroke severity and thrombolysis on outcomes following urgent carotid interventions. J Vasc Surg. 2023. PMID: 37330150. doi:10.1016/j.jvs.2023.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。